Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Voglibose preclinical results described at Japanese congress

Sep. 8, 1997

Genentech discontinues IGF-I development for type I and II diabetes

Sep. 8, 1997

GH secretagogues claimed by Novo Nordisk

Sep. 8, 1997

Sequana and Glaxo Wellcome near discovery of diabetes genes

Sep. 8, 1997

ENDOcare's device for abnormal uterine bleeding enters clinical trials

Sep. 8, 1997

Vertex and Alpha Therapeutic end hemoglobin collaboration

Sep. 4, 1997

Long-term U.S. clinical trial results for orlistat reported in Stockholm

Sep. 3, 1997

Pfizer identifies potent cholesterol absorption inhibitors

Sep. 3, 1997

Crinone launched in the U.S.

Sep. 3, 1997

Mayo Clinic, Wyeth-Ayerst plan fen/phen study

Aug. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...